Asst. Prof. @PennMedicine | @NIDCR K99/R00 Fellow | Cell Cycle | DNA Damage | HPV | TME | head & neck cancer | @fredhutch & @LifeAtPurdue | He | Tweets my own
Huge congratulations to Dr Jennifer Douglas @Penn_ENT for her P50 grant with collaborators @ Monell Chemical Senses Center! Incredible accomplishment for this surgeon:scientist star.
It was a privilege to present today at the 9th annual DDR Summit in Boston , representing the @PennCancer
team advancing translational science and clinical trials for HPV+ head and neck cancer @DiabLabPenn@DrNickLukens@LovaSunMD
I’m coming to New Orleans in April to give a talk and would love to see about bringing our science to other institutions in the area. Anyone have opportunities for this? Hematopoiesis, cancer biology, stem cells, glycans?
🚨 Calling all postdocs 🚨
We are soliciting applications to our 8th cohort of Fred Hutch Dr. Eddie Méndez Scholars! Awardees will be invited to present at a symposium celebrating their achievements 🧵
Apply here 👇 👇 👇
https://t.co/PE5oN1OCoo
📆 Applications due 2/1/2026
I am at #SITC25 . I’m looking for a second postdoc to join my tumor immunology lab at UCSF. So, if you’re graduating soon etc. and here, message me or drop your poster number in the comments!!
What's the difference between Trm and exhausted CD8 T cells? Simone Park's new work dissects this important question. These cell types are often confused, but are ontologically and mechanistically distinct with implications for immunotherapy responses. https://t.co/i8qksekdNM
Proud of my student, Jidapa Janpathompong, for delivering an outstanding presentation on her summer research at the SUIP Symposium at Penn. Huge thanks to everyone who made this event a success!
@RTAatPennMed@parkerici@PennMedicine@bradylabupenn
Boom!💥 @FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. https://t.co/RXSqwO03t5
Thanks to @NIH-supported research, baby KJ successfully received personalized gene therapy treatment for CPS1, a life-threatening, incurable genetic disease. This marks the first time this technology has been successfully used to treat a human patient.
The 2024 Young Investigator Awards recipients have just been announced. Congrats to this year’s class, who received $6.3 million in funding for innovative prostate cancer research.
Meet this year’s class: https://t.co/9ZJR85TxCg
#ProstateCancer#MedEd#MedX
Congrats to @EJohnWherry, PhD, Co-Director of the PICI Center at @PennMedicine, on his election to the @theNASciences—one of the highest honors in American science! His discoveries in T cell exhaustion and checkpoint pathways have transformed cancer immunotherapy and continue to shape the field.
https://t.co/EbiZOh5SGW
#Immunotherapy #CancerImmunotherapy #NASmembers
Job alert! We are looking for postdoc interested in quantitative methods to understand metabolic programming in cancer and immune cells! Also recruiting technician to help manage lab instruments and projects. DM or email me or forward to anyone you think that might be interested!